Susunod

Auto-play

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 Mga view • 07/03/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play